Translocator protein 18 kDa negatively regulates inflammation in microglia

Journal of Neuroimmune Pharmacology

Volumn 9, Issue 3, 2014, Pages 424-437

  Bae, Keun Ryung ^a   Shim, Hyun Jung ^a   Balu, Deebika ^b,c   Kim, Sang Ryong ^a,d   Yu, Seong Woon ^a  

^a Daegu Gyeongbuk Institute of Science and Technology   (South Korea)

^b Michigan State University   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Kyungpook National University   (South Korea)

Author keywords

Microglia; Neurodegeneration; Neuroinflammation; NF B; Translocator protein 18 kDa

Indexed keywords

BETA ACTIN; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOCHONDRIAL PROTEIN; OUTER MEMBRANE PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSLOCATOR PROTEIN 18 KDA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; AUTACOID; BZRP PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; GENE EXPRESSION; MALE; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL LINE; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL LINE; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; RECEPTORS, GABA;

EID: 84901258484     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-014-9540-6     Document Type: Article

References (53)

1. Barron AM, Garcia-Segura LM, Caruso D, Jayaraman A, Lee JW, Melcangi RC, Pike CJ (2013) Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease. J Neurosci 15(33):8891-8897
2. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57-69 (Pubitemid 46011999)
3. Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, Kettenmann H (1992) An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res 31:616-621.B
4. Buck JR, McKinley ET, Hight MR, Fu A, Tang D, Smith RA, Tantawy MN, Peterson TE, Colvin D, Ansari MS, Baldwin RM, Zhao P, Guleryuz S, Manning HC (2011) Quantitative, preclinical PET of translocator protein expression in glioma using 18 F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline. J Nucl Med 52:107-114
5. Cagnin A, Rossor M, Sampson EL, Mackinnon T, Banati RB (2004) In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol 56:894-897 (Pubitemid 39578457)
6. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9:917-924 (Pubitemid 43980506)
7. Chen MK, Guilarte TR (2008) Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther 118:1-17
8. Choi J, Ifuku M, Noda M, Guilarte TR (2011) Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state. Glia 59:219-230
9. Cicchetti F, Brownell AL,Williams K, Chen YI, Livni E, Isacson O (2002) Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohisto-chemistry and PET imaging. Eur J Neurosci 15:991-998 (Pubitemid 35463634)
10. Dauer W, Przedborski S (2003) Parkinson's disease: review mechanisms and models. Neuron 39:889-909 (Pubitemid 37130207)
11. Delavoie F, Li H, Hardwick M, Robert JC, Giatzakis C, Péranzi G, Yao ZX, Maccario J, Lacapère JJ, Papadopoulos V (2003) In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42:4506-4519 (Pubitemid 36457619)
12. 11C] PIB-PET study. Neurobiol Dis 32:412-419
13. Gao HM, Zhou H, Zhang F, Wilson BC, Kam W, Hong JS (2011) HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J Neurosci 31:1081-1092
14. Giulian D (1993) Reactive glia as rivals in regulating neuronal survival. Glia 7:102-110
15. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918-934
16. Gottfried-Blackmore A, Sierra A, Jellinck PH, McEwen BS, Bulloch K (2008) Brain microglia express steroid-converting enzymes in the mouse. J Steroid Biochem Mol Biol 109:96-107
17. Harms AS, Barnum CJ, Ruhn KA, Varghese S, Treviño I, Blesch A, Tansey MG (2011) Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease. Mol Ther 19:46-52
18. Jayakumar AR, Panickar KS, Norenberg MD (2002) Effects on free radical generation by ligands of the peripheral benzodiazepine receptor in cultured neural cells. J Neurochem 83:1226-1234 (Pubitemid 35397132)
19. Jeong HK, Ji K, Min K, Joe EH (2013) Brain inflammation: facts and misconceptions. Exp Neurobiol 22:59-67
20. Jordà EG, Jiménez A, Verdaguer E, Canudas AM, Folch J, Sureda FX, Camins A, Pallàs M (2005) Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis. Apoptosis 10:91-104
21. Khasnavis S, Jana A, Roy A, Mazumder M, Bhushan B, Wood T, Ghosh S,Watson R, Pahan K (2012) Suppression of nuclear factor-kappa B activation and inflammation in microglia by a physically-modified saline. J Biol Chem 287:29529-29542
22. Kim SR, Chung ES, Bok E, Baik HH, Chung YC, Won SY, Joe E, Kim TH, Kim SS, JinMY, Choi SH, Jin BK (2010) Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation. J Neurosci Res 88:1537-1548
23. +, specifically impairs mitochondrial transport in dopamine axons. J Neurosci 31:7212-7221
24. Knott C, Stern G, Wilkin GP (2000) Inflammatory regulators in Parkinson 's disease: iNOS, lipocortin-1 and cyclooxygenases-1 and -2.Mol Cell Neurosci 16:724-727
25. Lacapere JJ, Papadopoulos V (2003) Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 68:569-585
26. Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyri dineexposure. Ann Neurol 46:598-605 (Pubitemid 29466438)
27. Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution andmorphology of microglia in the normal adult mouse brain. Neuroscience 39:151-170
28. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, Vartanian T (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22:2478-2486 (Pubitemid 37465796)
29. Levesque S, Wilson B, Gregoria V, Thorpe LB, Dallas S, Polikov VS, Hong JS, Block ML (2010) Reactive microgliosis: extracellular μ-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 133:808-821
30. Liu Y, Hu J, Wu J, Zhu C, Hui Y, Han Y, Huang Z, Ellsworth K, Fan W (2012) Alpha7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. J Neuroinflammation 24:98-113
31. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-delta delta C (T)) method. Methods 25:402-408 (Pubitemid 34164012)
32. Lull ME, Block ML (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics 7:354-365
33. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-686 (Pubitemid 39457982)
34. Marta F, Davide L, Maria PA (2011) Role of purinergic signaling in neuro-immune cells and adult neural progenitors. Front Biosci 16:2326-2341
35. Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453-461 (Pubitemid 351599757)
36. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-969
37. Nomura DK, Morrison BE, Blankman JL, Long JZ, Kinsey SG, Marcondes MC, Ward AM, Hahn YK, Lichtman AH, Conti B, Cravatt BF (2011) Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334:809-813
38. Orr CF, Rowe DB, Halliday GM (2002) An inflammatory review of Parkinson's disease. Prog Neurobiol 68:325-340 (Pubitemid 36071510)
39. Ostuni MA, Issop L, Péranzi G, Walker F, Fasseu M, Elbim C, Papadopoulos V, Lacapere JJ (2010) Overexpression of translocator protein TSPO in inflammatory bowel disease: potential diagnostic and treatment value. Inflamm Bowel Dis 16:1476-1487
40. Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005)Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol 57:168-175 (Pubitemid 40179853)
41. Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX (2006) Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 138:749-756
42. Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, Brooks DJ, Piccini P (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PETstudy.Neurology 66:1638-1643 (Pubitemid 43964614)
43. Rick CE, Ebert A, Virag T, Bohn MC, Surmeier DJ (2006) Differentiated dopaminergic MN9D cells only partially recapitulate the electrophysiological properties of midbrain dopaminergic neurons. Dev Neurosci 28:528-537 (Pubitemid 44532981)
44. Roy A, Fung YK, Liu X, Pahan K (2006) Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem 281:14971-14980 (Pubitemid 43855201)
45. Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Groyer G, Adams D, Schumacher M (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9:971-988
46. Saijo K, Collier JG, Li AC, Katzenellenbogen JA, Glass CK (2011) An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia mediated inflammation. Cell 145:584-595
47. Schachtrup C, Ryu JK, Helmrick MJ, Vagena E, Galanakis DK, Degen JL, Margolis RU, Akassoglou AD (2010) Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-β after vascular damage. J Neurosci 17:5843-5854
48. 11C] (R)-PK11195 positron emission tomography study. Neurobiol Dis 15:601-609
49. Versijpt J, Debruyne JC, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, Achten E, Slegers G, Dierckx RA, Korf J, De Reuck JL (2005) Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult Scler 11:127-134 (Pubitemid 40403248)
50. Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, Antel JP (1997) PK11195 binding to the peripheral benzodiazepine receptor as amarker ofmicroglia activation inmultiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 50:345-353 (Pubitemid 27473649)
51. 11C] DAA1106. Biol Psychiatry 64:835-841
52. Zhang F, Shi JS, Zhou H, Wilson B, Hong JS, Gao HM (2010) Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol Pharmacol 78:466-477
53. Zhao YY, Yu JZ, Li QY,Ma CG, Lu CZ, Xiao BG (2011) TSPO-specific ligand Vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation. Neuron Glia Biol 7:187-197